MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 7, 2006; DOI: 10.1124/mol.105.019414


0026-895X/06/6905-1652-1661$20.00
Mol Pharmacol 69:1652-1661, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019414v1
69/5/1652    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Springael, J.-Y.
Right arrow Articles by Parmentier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Springael, J.-Y.
Right arrow Articles by Parmentier, M.

Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers

Jean-Yves Springael, Phu Nguyen Le Minh, Eneko Urizar, Sabine Costagliola, Gilbert Vassart, and Marc Parmentier

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium

We have demonstrated previously that the chemokine receptors CCR2 and CCR5 form homo- and heterodimers and that dimers can only bind a single chemokine molecule with high affinity. We provide here evidence from bioluminescence resonance energy transfer experiments that stimulation by chemokines does not influence the CCR2/CCR5 heterodimerization status. In addition, we show that the rate of radioligand dissociation from one unit of the heterodimer in "infinite" tracer dilution conditions is strongly increased in the presence of an unlabeled chemokine ligand of the other unit. These results demonstrate unambiguously that the interaction between heterodimer units is of allosteric nature. Agonists, but also some monoclonal antibodies, could promote such negative binding cooperativity, indicating that this phenomenon does not require the full conformational change associated with receptor activation. Finally, we show that G protein coupling is required for high-affinity binding of macrophage inflammatory protein-1beta (CCL4) to CCR5 and that the dissociation from G proteins, after incubation with Gpp(NH)p, promotes the release of prebound radiolabeled chemokines with kinetics similar to those measured after the addition of an excess of unlabeled chemokines. These observations suggest that the association with G proteins probably participates in the negative cooperativity observed between receptor monomers. We propose that negative cooperativity within homo- and heterodimers of chemokine receptors and probably other G protein-coupled receptors will probably have major implications in their pharmacology in vivo and in the physiopathology of the diseases with which they are associated.


Received September 29, 2005; accepted February 7, 2006

Address correspondence to: Dr. Marc Parmentier, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Campus Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium. E-mail: mparment{at}ulb.ac.be




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Gouwy, S. Struyf, S. Noppen, E. Schutyser, J.-Y. Springael, M. Parmentier, P. Proost, and J. Van Damme
Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events
Mol. Pharmacol., August 1, 2008; 74(2): 485 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Damian, S. Mary, A. Martin, J.-P. Pin, and J.-L. Baneres
G Protein Activation by the Leukotriene B4 Receptor Dimer: EVIDENCE FOR AN ABSENCE OF TRANS-ACTIVATION
J. Biol. Chem., July 25, 2008; 283(30): 21084 - 21092.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie
CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Blood, July 1, 2008; 112(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L. Szidonya, M. Cserzo, and L. Hunyady
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions
J. Endocrinol., March 1, 2008; 196(3): 435 - 453.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Svendsen, M. Vrecl, T. M. Ellis, A. Heding, J. B. Kristensen, J. D. Wade, R. A. D. Bathgate, P. De Meyts, and J. Nohr
Cooperative Binding of Insulin-Like Peptide 3 to a Dimeric Relaxin Family Peptide Receptor 2
Endocrinology, March 1, 2008; 149(3): 1113 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Sohy, M. Parmentier, and J.-Y. Springael
Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers
J. Biol. Chem., October 12, 2007; 282(41): 30062 - 30069.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J.-P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, J. A. Javitch, M. J. Lohse, G. Milligan, K. Palczewski, M. Parmentier, et al.
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers
Pharmacol. Rev., March 1, 2007; 59(1): 5 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. A. Berchiche, K. Y. Chow, B. Lagane, M. Leduc, Y. Percherancier, N. Fujii, H. Tamamura, F. Bachelerie, and N. Heveker
Direct Assessment of CXCR4 Mutant Conformations Reveals Complex Link between Receptor Structure and G{alpha}i Activation
J. Biol. Chem., February 23, 2007; 282(8): 5111 - 5115.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-C. Twizere, J.-Y. Springael, M. Boxus, A. Burny, F. Dequiedt, J.-F. Dewulf, J. Duchateau, D. Portetelle, P. Urbain, C. V. Lint, et al.
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling
Blood, February 1, 2007; 109(3): 1051 - 1060.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ellis, J. D. Pediani, M. Canals, S. Milasta, and G. Milligan
Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function
J. Biol. Chem., December 15, 2006; 281(50): 38812 - 38824.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Albizu, M.-N. Balestre, C. Breton, J.-P. Pin, M. Manning, B. Mouillac, C. Barberis, and T. Durroux
Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding
Mol. Pharmacol., November 1, 2006; 70(5): 1783 - 1791.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics